A REVIEW ON PARKINSON’S DISEASE: ITS PATHOPHYSIOLOGY, TREATMENT AND SURGERY
{ DOWNLOAD AS PDF }
ABOUT AUTHORS:
Singh Divya1, Siddhi Shrimali2, Rathore KS2*
1Department of Pharmacology, Jaipur College of Pharmacy, Jaipur, Rajasthan, India
2Department of Pharmaceutics, BN Institute of Pharmaceutical Sciences, Udaipur, Rajasthan, India
*kamalsrathore@gmail.com
ABSTRACT
Parkinsonism disease (PD) is a progressive neurological disorder. Degeneration of dopamine producing cells in the substantia nigra (part of the basal ganglia) leads to a decreased dopamine production. The cause of the damage is unknown. The main known risk factor is age. Parkinson’s affects functional activities such as balance, walking, speech, handwriting, typing, fastening buttons, driving, and many other simple, or complex but familiar and routine activities, as they are usually controlled by the mechanisms of dopamine and the basal ganglia. This review briefly focuses on deep brain stimulation neurosurgical treatment. Levodopa was the first drug approved specifically for Parkinson’s disease. Levodopa is converted by enzymes in the brain to produce dopamine, thereby supplementing function that has been lost as dopamine-producing neurons die.Topics covered in the review includes pathogenesis, mechanism of action, side effects of medicines and neurological surgery.

ABOUT AUTHORS:
Evolet is the pioneer in the field of rendering services of outsourcing – in production of pharmaceutical production on the basis of contract manufacturing.
ABOUT AUTHORS:
The Confederation of Indian Industry (CII) works to create and sustain an environment conducive to the development of India, partnering industry, Government, and civil society, through advisory and consultative processes. CII is a non-government, not-for-profit, industry-led and industry-managed organization, playing a proactive role in India's development process. Founded in 1895, India's premier business association has over 7200 members, from the private as well as public sectors, including SMEs and MNCs, and an indirect membership of over 100,000 enterprises from around 242 national and regional sectoral industry bodies.
